These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
127 related articles for article (PubMed ID: 16386525)
1. Updated metaanalysis of steroid withdrawal in renal transplant patients on calcineurin inhibitor and mycophenolate mofetil. Pascual J; Quereda C; Zamora J; Hernández D; Transplant Proc; 2005 Nov; 37(9):3746-8. PubMed ID: 16386525 [TBL] [Abstract][Full Text] [Related]
2. Steroid withdrawal in renal transplant patients on triple therapy with a calcineurin inhibitor and mycophenolate mofetil: a meta-analysis of randomized, controlled trials. Pascual J; Quereda C; Zamora J; Hernández D; Transplantation; 2004 Nov; 78(10):1548-56. PubMed ID: 15599321 [TBL] [Abstract][Full Text] [Related]
3. Early steroid withdrawal therapy in renal transplant recipients: a steroid-free sirolimus and CellCept-based calcineurin inhibitor-minimization protocol. Jaber JJ; Feustel PJ; Elbahloul O; Conti AD; Gallichio MH; Conti DJ Clin Transplant; 2007; 21(1):101-9. PubMed ID: 17302598 [TBL] [Abstract][Full Text] [Related]
4. Early steroid withdrawal protocol with basiliximab, cyclosporine and mycophenolate mofetil in renal-transplant recipients. Kato Y; Tojimbara T; Iwadoh K; Koyama I; Nanmoku K; Kai K; Sannomiya A; Nakajima I; Fuchinoue S; Teraoka S Int Immunopharmacol; 2006 Dec; 6(13-14):1984-92. PubMed ID: 17161352 [TBL] [Abstract][Full Text] [Related]
5. Randomized trial of tacrolimus versus cyclosporine in steroid withdrawal in living donor renal transplant recipients. Kim SJ; Lee KW; Lee DS; Lee HH; Lee SK; Kim B; Huh WS; Oh HY; Joh JW Transplant Proc; 2004 Sep; 36(7):2098-100. PubMed ID: 15518759 [TBL] [Abstract][Full Text] [Related]
10. Comparative study of clinical outcome in kidney transplantation between early steroid withdrawal protocol using basiliximab, calcineurin inhibitor, and mycophenolate mofetil and triple regimen consisting of calcineurin inhibitor, mycophenolate mofetil, and steroid. Teraoka S; Sato S; Sekijima M; Iwado K; Urashima Y; Kudo S; Kai K; Koyama I; Tojinbara T; Nakajima I; Fuchinoue S Transplant Proc; 2005 Mar; 37(2):791-4. PubMed ID: 15848533 [TBL] [Abstract][Full Text] [Related]
11. Graft survival following living-donor renal transplantation: a comparison of tacrolimus and cyclosporine microemulsion with mycophenolate mofetil and steroids. Bunnapradist S; Daswani A; Takemoto SK Transplantation; 2003 Jul; 76(1):10-5. PubMed ID: 12865780 [TBL] [Abstract][Full Text] [Related]
13. The safety and efficacy of early withdrawal of calcineurin inhibitors in kidney transplant recipients 6 months' posttransplant. Boswell A; Evans L; Rigg K; Shehata M Transplant Proc; 2005 Mar; 37(2):884-5. PubMed ID: 15848564 [TBL] [Abstract][Full Text] [Related]
14. Freedom from rejection and stable kidney function are excellent criteria for steroid withdrawal in tacrolimus-treated kidney transplant recipients. Włodarczyk Z; Wałaszewski J; Perner F; Vitko S; Ostrowski M; Bachleda P; Kokot F; Klinger M; Szenohradsky P; Studenik P; Navratil P; Asztalos L; Rutkowski B; Nagy KK; Hickey D Ann Transplant; 2002; 7(3):28-31. PubMed ID: 12465429 [TBL] [Abstract][Full Text] [Related]
15. Steroids can be safely withdrawn from cyclosporine and mycophenolate mofetil-treated renal allograft recipients: long-term results. Rama I; Cruzado JM; Gil-Vernet S; Torras J; Serón D; Castelao AM; Ibernón M; Bestard O; Grinyó JM Transplantation; 2005 Jul; 80(2):164-8. PubMed ID: 16041259 [TBL] [Abstract][Full Text] [Related]
16. Three-year observational follow-up of a multicenter, randomized trial on tacrolimus-based therapy with withdrawal of steroids or mycophenolate mofetil after renal transplant. Pascual J; van Hooff JP; Salmela K; Lang P; Rigotti P; Budde K Transplantation; 2006 Jul; 82(1):55-61. PubMed ID: 16861942 [TBL] [Abstract][Full Text] [Related]
17. Kidney transplantation with sirolimus and mycophenolate mofetil-based immunosuppression: 5-year results of a randomized prospective trial compared to calcineurin inhibitor drugs. Flechner SM; Goldfarb D; Solez K; Modlin CS; Mastroianni B; Savas K; Babineau D; Kurian S; Salomon D; Novick AC; Cook DJ Transplantation; 2007 Apr; 83(7):883-92. PubMed ID: 17460558 [TBL] [Abstract][Full Text] [Related]
18. Early steroid withdrawal in pediatric renal transplantation at a single center: preliminary report. Valenzuela M; Delucchi A; Ferrario M; Lillo AM; Guerrero JL; Rodríguez E; Cano F; Cavada G Transplant Proc; 2008 Nov; 40(9):3237-40. PubMed ID: 19010242 [TBL] [Abstract][Full Text] [Related]
19. Prospective, randomized trial of steroid withdrawal in kidney recipients treated with mycophenolate mofetil and cyclosporine. Pelletier RP; Akin B; Ferguson RM Clin Transplant; 2006; 20(1):10-8. PubMed ID: 16556147 [TBL] [Abstract][Full Text] [Related]
20. Is acute rejection the key predictor for long-term outcomes after renal transplantation when comparing calcineurin inhibitors? Nashan B Transplant Rev (Orlando); 2009 Jan; 23(1):47-52. PubMed ID: 19027616 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]